Optimizing the adenoma detection rate (ADR) is a major goal in colorectal cancer (CCR)
screening, as it has long been established that ADR is inversely proportional to the risk of
post-colonoscopy CRC occurrence. To achieve this goal, many optimization devices have been
developed, and numerous randomized controlled trials have been conducted to evaluate the
benefits of these devices compared with a "standard arm," which corresponds to date to
high-definition white light (HD-WLI) colonoscopy. Numerous studies have confirmed the positive
impact of various optimization devices, such as caps, computer-aided detection, and
contrast-enhanced technologies. Moreover, the different ways in which the devices can impact
ADR make them complementary. However, despite substantial and consistent data, practices
remain unchanged, and HD-WLI colonoscopy, considered the "standard," is still routinely
performed without any optimization devices. The objective of this viewpoint is to understand
the barriers to change and to show why standard screening colonoscopy without the use of any
optimization devices should no longer be considered relevant in 2024.